Day: September 6, 2023

HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Chief Executive Officer George Ng will present a corporate overview at the at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel. Presentation Date: September 13, 2023 Time: 3:30pm ET Webcast Link: https://journey.ct.events/view/ce209a76-e148-4890-bd72-de6478b6e5f6 Mr. Ng and Chief Financial Officer James Stanker will be available for one-on-one meetings throughout the conference. Investors can attend the conference...

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.Presentation Date: September 13, 2023   Time: 8:30am ET Webcast Link:   https://journey.ct.events/view/a2bb617e-99c0-4e6c-8b4a-15d80a10a66f A live webcast of the presentation can be accessed on the investor relations section of the Indaptus website. A replay of the webcast will be archived and available following the event for approximately 90 days. https://indaptusrx.com/investors/events-presentations/ Mr. Meckler will be available for one-on-one meetings throughout...

ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21, 2023. Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business. The bioprocessing business is anchored by the STx and VLx platforms supporting biotherapeutic research, development and manufacturing using transient expression to produce complex proteins, vaccines and biologics at scale. “With his commercial background, strategic insight...

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023, at the Lotte New York Palace Hotel in New York, NY. Details are as follows: H.C. Wainwright 25th Annual Global Investment Conference Corporate Presentation: Tuesday, September 12, 2023, from 11:30 AM-12:00 PM ET Webcast Link: https://journey.ct.events/view/7d04fb43-ff26-406f-9676-dc4aa23e674d The...

Specific coding expected to improve disease awareness, understanding and diagnosis and may enhance access to therapies for patients with BBS BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that a new International Classification of Diseases, Tenth Revision (ICD-10) diagnosis code for Bardet-Biedl Syndrome (BBS) was approved by the Centers for Disease Control and Prevention (CDC). The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023. “Finding and connecting patients, families and physicians across the country has been extremely challenging...

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX)  (“Barrick”) announced today that following the August 24, 2023 closing of a private placement of units (the “Private Placement”) by Cascadia Minerals Ltd. (“Cascadia”), Barrick’s 2,788,696 common shares of Cascadia represent approximately 7.6% of Cascadia’s outstanding common shares. Barrick did not acquire any securities in the Private Placement and, as a result of the Private Placement, Barrick has ceased to be an insider of Cascadia pursuant to Canadian securities laws. Barrick is holding its Cascadia common shares for investment purposes. Depending on market conditions and other factors, including Cascadia’s business and financial condition, Barrick may acquire additional common shares or other securities of Cascadia or dispose of some...

MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) — Star Parent, Inc. (the “Issuer” or the “Company”) and Syneos Health, Inc. (“Syneos Health”), announced today that, subject to market conditions and other factors, the Issuer intends to offer $1,700,000,000 aggregate principal amount of Senior Secured Notes due 2030 (the “Notes”). The Issuer intends to use the proceeds from the offering together with other financing sources to fund the previously announced acquisition of Syneos Health (the “Acquisition”) by the Issuer and certain of its affiliated entities (such affiliates, together with the Issuer, the “Purchasing Entities”) and related refinancings. The Purchasing Entities were newly-formed entities established by a consortium of private investment funds led by Elliott Investment Management L.P. and its affiliates, Patient Square...

Figure 1Childress – Phase 1 (100MW) construction progressFigure 2Childress – second data center building foundationDaily average operating hashrate chartDaily average operating hashrate chartNegative 8c Power at Childress in August Targeting Next-Gen Compute and Generative AI with NVIDIA H100 GPUs SYDNEY, Australia, Sept. 06, 2023 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (“Iris Energy” or “the Company”), a leading owner and operator of institutional-grade, highly efficient proprietary Bitcoin mining data centers powered by 100% renewable energy, today published a monthly investor update for August 2023, containing its results from operations as well as business updates. Key Highlights1Key metrics2 Aug-23Average operating hashrate (PH/s) 5,493Bitcoin mined 410Mining...